C58, Malignant neoplasm of placentaICD-10-CM
No Prior Auth Required
Code is covered without prior authorization (high confidence)
CGS-L38067, MolDX: Next-Generation Sequencing for Solid Tumors
J15
CGS-L38065, MolDX: Plasma-Based Genomic Profiling in Solid Tumors
J15
CGS-L38822, MolDX: Minimal Residual Disease Testing for Cancer
J15
CGS-L34356, Erythropoiesis Stimulating Agents (ESA)
J15
Ask Verity about documentation requirements, denial risks, or coverage in your state.
J15
CGS-L36658, Proton Beam Therapy
J15
CGS-L40225, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
J15
A58468, Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
J5
A57936, Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
J5
A57858, Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
J5
A57452, Billing and Coding: Peripheral Nerve Blocks
J6
A56827, Billing and Coding: Proton Beam Therapy
J6
A56867, Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms
J6
WPS-L40277, MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
J8
WPS-L38835, MolDX: Minimal Residual Disease Testing for Cancer
J8
WPS-L38168, MolDX: Plasma-Based Genomic Profiling in Solid Tumors
J8
WPS-L38158, MolDX: Next-Generation Sequencing for Solid Tumors
J8
FIRST_COAST-L33933, Peripheral Nerve Blocks
J9
NGS-L36850, Peripheral Nerve Blocks
JK
NGS-L35075, Proton Beam Therapy
JK